CDK-INHIBITING DERIVATIVES OF 4-(IMIDASOL-5-YL)-2-(4-SULFOANILINO)PYRIMIDINE

Compounds of the formula (I): wherein R', R2, R3, R4, R5 and p are as defined within and a pharmaceutically acceptable salts and in vivo hydrolysable esters are described. Also described are processes for their preparation and their use as medicaments, particularly medicaments for producing a c...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	THOMAS ANDREW PETER, NEWCOMBE NICHOLAS JOHN
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	THOMAS ANDREW PETER NEWCOMBE NICHOLAS JOHN
description	Compounds of the formula (I): wherein R', R2, R3, R4, R5 and p are as defined within and a pharmaceutically acceptable salts and in vivo hydrolysable esters are described. Also described are processes for their preparation and their use as medicaments, particularly medicaments for producing a cell cycle inhibitory (anti-cell-proliferation) effect in a warm-blooded animal, such as man. (I)
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_UA78292C2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>UA78292C2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_UA78292C23</originalsourceid><addsrcrecordid>eNrjZPBxdvHW9fTz8HTyDPH0c1dwcQ3yDHMM8QxzDVbwd1Mw0dXw9PV0cQz299E11Y300dQ10tUw0Q0O9XHzd_Tz9PH089cMiAwCqfH0c-VhYE1LzClO5YXS3Axybq4hzh66qQX58anFBYnJqXmpJfGhjuYWRpZGzkbGBBUAAGgbLDk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CDK-INHIBITING DERIVATIVES OF 4-(IMIDASOL-5-YL)-2-(4-SULFOANILINO)PYRIMIDINE</title><source>esp@cenet</source><creator>THOMAS ANDREW PETER ; NEWCOMBE NICHOLAS JOHN</creator><creatorcontrib>THOMAS ANDREW PETER ; NEWCOMBE NICHOLAS JOHN</creatorcontrib><description>Compounds of the formula (I): wherein R', R2, R3, R4, R5 and p are as defined within and a pharmaceutically acceptable salts and in vivo hydrolysable esters are described. Also described are processes for their preparation and their use as medicaments, particularly medicaments for producing a cell cycle inhibitory (anti-cell-proliferation) effect in a warm-blooded animal, such as man. (I)</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070315&DB=EPODOC&CC=UA&NR=78292C2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25544,76292</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070315&DB=EPODOC&CC=UA&NR=78292C2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>THOMAS ANDREW PETER</creatorcontrib><creatorcontrib>NEWCOMBE NICHOLAS JOHN</creatorcontrib><title>CDK-INHIBITING DERIVATIVES OF 4-(IMIDASOL-5-YL)-2-(4-SULFOANILINO)PYRIMIDINE</title><description>Compounds of the formula (I): wherein R', R2, R3, R4, R5 and p are as defined within and a pharmaceutically acceptable salts and in vivo hydrolysable esters are described. Also described are processes for their preparation and their use as medicaments, particularly medicaments for producing a cell cycle inhibitory (anti-cell-proliferation) effect in a warm-blooded animal, such as man. (I)</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPBxdvHW9fTz8HTyDPH0c1dwcQ3yDHMM8QxzDVbwd1Mw0dXw9PV0cQz299E11Y300dQ10tUw0Q0O9XHzd_Tz9PH089cMiAwCqfH0c-VhYE1LzClO5YXS3Axybq4hzh66qQX58anFBYnJqXmpJfGhjuYWRpZGzkbGBBUAAGgbLDk</recordid><startdate>20070315</startdate><enddate>20070315</enddate><creator>THOMAS ANDREW PETER</creator><creator>NEWCOMBE NICHOLAS JOHN</creator><scope>EVB</scope></search><sort><creationdate>20070315</creationdate><title>CDK-INHIBITING DERIVATIVES OF 4-(IMIDASOL-5-YL)-2-(4-SULFOANILINO)PYRIMIDINE</title><author>THOMAS ANDREW PETER ; NEWCOMBE NICHOLAS JOHN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_UA78292C23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2007</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>THOMAS ANDREW PETER</creatorcontrib><creatorcontrib>NEWCOMBE NICHOLAS JOHN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>THOMAS ANDREW PETER</au><au>NEWCOMBE NICHOLAS JOHN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CDK-INHIBITING DERIVATIVES OF 4-(IMIDASOL-5-YL)-2-(4-SULFOANILINO)PYRIMIDINE</title><date>2007-03-15</date><risdate>2007</risdate><abstract>Compounds of the formula (I): wherein R', R2, R3, R4, R5 and p are as defined within and a pharmaceutically acceptable salts and in vivo hydrolysable esters are described. Also described are processes for their preparation and their use as medicaments, particularly medicaments for producing a cell cycle inhibitory (anti-cell-proliferation) effect in a warm-blooded animal, such as man. (I)</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng
recordid	cdi_epo_espacenet_UA78292C2
source	esp@cenet
subjects	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title	CDK-INHIBITING DERIVATIVES OF 4-(IMIDASOL-5-YL)-2-(4-SULFOANILINO)PYRIMIDINE
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T09%3A17%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=THOMAS%20ANDREW%20PETER&rft.date=2007-03-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUA78292C2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true